A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells

Rupesh S Patel1,2,3,4, Rodrigo Romero5,6,7, Emma V Watson1,2,3

  • 1Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Nature Communications
|January 12, 2022
PubMed

Insights

The GATA4 transcription factor suppresses tumors by activating a secretory program that recruits immune cells. Activating this pathway with an anti-PD-1 antibody halts tumor growth, offering a potential cancer therapy.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • GATA4 is a key developmental regulator that also controls a pro-inflammatory secretory program.
  • This program is linked to senescence and tumorigenesis, and GATA4 is often lost in cancer.
  • The role of GATA4 in tumor suppression and its underlying mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of GATA4 in tumorigenesis using mouse models.
  • To elucidate the mechanisms by which GATA4 influences tumor suppression.
  • To explore therapeutic strategies targeting the GATA4-dependent secretory pathway.

Main Methods:

  • Loss-of-function and overexpression experiments in mouse models of tumorigenesis.
  • Analysis of Gata4-dependent secretory pathways, including chemokines like CCL2.
  • Assessment of immune cell involvement, particularly CD8 T cells.
  • Transcriptome analysis of human tumors and in vivo efficacy studies of combined therapy.

Main Results:

  • GATA4 was found to promote non-cell autonomous tumor suppression across multiple models.
  • Gata4-dependent tumor suppression necessitates cytotoxic CD8 T cells and is partially dependent on CCL2.
  • Human tumors lacking GATA4 show reduced lymphocyte infiltration, mirroring murine findings.
  • Combining GATA4-secretory program activation with anti-PD-1 therapy effectively inhibited tumor growth.

Conclusions:

  • GATA4 functions as a non-cell autonomous tumor suppressor.
  • The GATA4-dependent secretory program, involving CD8 T cells and CCL2, is crucial for tumor suppression.
  • Targeting the GATA4 pathway in combination with immunotherapy presents a promising strategy for cancer treatment.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
3.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
712
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K